Search research articles
Contact Us
Filters
Showing results (201-210 of 337) with videos related to
Page
of 34
Sort By:
The Pediatric Infectious Disease Journal
|
February 16, 2012
Attitudes regarding occupational vaccines and vaccination coverage against vaccine-preventable diseases among healthcare workers working in pediatric departments in Greece
Helena C Maltezou, Athanasia Lourida, Aspasia Katragkou, et al.
Infection Control and Hospital Epidemiology
|
October 27, 2010
Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes
Eleni Mouloudi, Euthymia Protonotariou, Alexia Zagorianou, et al.
Journal of the Pediatric Infectious Diseases Society
|
March 23, 2016
Use of Tigecycline in Pediatric Patients With Infections Predominantly Due to Extensively Drug-Resistant Gram-Negative Bacteria
Elias Iosifidis, Asimenia Violaki, Evangelia Michalopoulou, et al.
Germs
|
January 25, 2021
Fulminant cryptococcal meningoencephalitis after successful treatment of primary cutaneous cryptococcosis
Iordanis Romiopoulos, Zoi Dorothea Pana, Athina Pyrpasopoulou, et al.
Pathogens (Basel, Switzerland)
|
January 28, 2026
Treating Extensively Drug-Resistant <i>Acinetobacter baumannii</i>: Considerations for Host Characteristics and Type of Infections
Anastasia Geladari, Dimitrios Kouroupis, Kyriaki Vafeidou, et al.
The Pediatric Infectious Disease Journal
|
January 19, 2024
Off-label Use of Ceftazidime/Avibactam in Neonatal Intensive Care Unit: A Real-life Experience and Literature Review
Argyro Ftergioti, Melania Degli Antoni, Angeliki Kontou, et al.
Trials
|
April 16, 2020
An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial
Louise F Hill, Mark A Turner, Irja Lutsar, et al.
Antimicrobial Agents and Chemotherapy
|
March 30, 2021
Population Pharmacokinetics and Outcomes of Critically Ill Pediatric Patients Treated with Intravenous Colistin at Higher Than Recommended Doses
Charalampos Antachopoulos, Anastasia Geladari, Cornelia B Landersdorfer, et al.
Acta Neurochirurgica
|
July 26, 2016
Nosocomial bloodstream infections in neurosurgery: a 10-year analysis in a center with high antimicrobial drug-resistance prevalence
Parmenion P Tsitsopoulos, Elias Iosifidis, Charalampos Antachopoulos, et al.
The Journal of Antimicrobial Chemotherapy
|
October 8, 2014
In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms
Aspasia Katragkou, Matthew McCarthy, Elizabeth L Alexander, et al.
Page
of 34
Search research articles
Search
Showing results (201-210 of 337) with videos related to
Sort By:
Page
of 34
The Pediatric Infectious Disease Journal
|
February 16, 2012
Attitudes regarding occupational vaccines and vaccination coverage against vaccine-preventable diseases among healthcare workers working in pediatric departments in Greece
Helena C Maltezou, Athanasia Lourida, Aspasia Katragkou, et al.
Infection Control and Hospital Epidemiology
|
October 27, 2010
Bloodstream infections caused by metallo-β-lactamase/Klebsiella pneumoniae carbapenemase-producing K. pneumoniae among intensive care unit patients in Greece: risk factors for infection and impact of type of resistance on outcomes
Eleni Mouloudi, Euthymia Protonotariou, Alexia Zagorianou, et al.
Journal of the Pediatric Infectious Diseases Society
|
March 23, 2016
Use of Tigecycline in Pediatric Patients With Infections Predominantly Due to Extensively Drug-Resistant Gram-Negative Bacteria
Elias Iosifidis, Asimenia Violaki, Evangelia Michalopoulou, et al.
Germs
|
January 25, 2021
Fulminant cryptococcal meningoencephalitis after successful treatment of primary cutaneous cryptococcosis
Iordanis Romiopoulos, Zoi Dorothea Pana, Athina Pyrpasopoulou, et al.
Pathogens (Basel, Switzerland)
|
January 28, 2026
Treating Extensively Drug-Resistant <i>Acinetobacter baumannii</i>: Considerations for Host Characteristics and Type of Infections
Anastasia Geladari, Dimitrios Kouroupis, Kyriaki Vafeidou, et al.
The Pediatric Infectious Disease Journal
|
January 19, 2024
Off-label Use of Ceftazidime/Avibactam in Neonatal Intensive Care Unit: A Real-life Experience and Literature Review
Argyro Ftergioti, Melania Degli Antoni, Angeliki Kontou, et al.
Trials
|
April 16, 2020
An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial
Louise F Hill, Mark A Turner, Irja Lutsar, et al.
Antimicrobial Agents and Chemotherapy
|
March 30, 2021
Population Pharmacokinetics and Outcomes of Critically Ill Pediatric Patients Treated with Intravenous Colistin at Higher Than Recommended Doses
Charalampos Antachopoulos, Anastasia Geladari, Cornelia B Landersdorfer, et al.
Acta Neurochirurgica
|
July 26, 2016
Nosocomial bloodstream infections in neurosurgery: a 10-year analysis in a center with high antimicrobial drug-resistance prevalence
Parmenion P Tsitsopoulos, Elias Iosifidis, Charalampos Antachopoulos, et al.
The Journal of Antimicrobial Chemotherapy
|
October 8, 2014
In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms
Aspasia Katragkou, Matthew McCarthy, Elizabeth L Alexander, et al.
Page
of 34